UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 90 filers reported holding UTAH MED PRODS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,891,054 | +24.1% | 21,989 | +34.4% | 0.00% | 0.0% |
Q2 2023 | $1,524,379 | +197358.4% | 16,356 | +100.7% | 0.00% | – |
Q1 2023 | $772 | -99.8% | 8,151 | +135.2% | 0.00% | – |
Q1 2022 | $311,000 | +23.4% | 3,465 | +17.1% | 0.00% | – |
Q2 2021 | $252,000 | -74.6% | 2,960 | -74.2% | 0.00% | -100.0% |
Q1 2021 | $992,000 | -23.6% | 11,453 | -25.6% | 0.00% | 0.0% |
Q4 2020 | $1,298,000 | -37.6% | 15,402 | -40.9% | 0.00% | -66.7% |
Q3 2020 | $2,080,000 | +12.3% | 26,044 | +24.6% | 0.00% | 0.0% |
Q2 2020 | $1,853,000 | +817.3% | 20,905 | +813.3% | 0.00% | – |
Q1 2019 | $202,000 | -49.0% | 2,289 | -45.6% | 0.00% | – |
Q3 2018 | $396,000 | +97.0% | 4,207 | +130.1% | 0.00% | – |
Q2 2018 | $201,000 | -61.3% | 1,828 | -71.4% | 0.00% | -100.0% |
Q4 2017 | $520,000 | -32.8% | 6,392 | -39.2% | 0.00% | 0.0% |
Q3 2017 | $774,000 | -31.0% | 10,517 | -32.1% | 0.00% | -50.0% |
Q2 2017 | $1,122,000 | +272.8% | 15,492 | +220.9% | 0.00% | +100.0% |
Q1 2017 | $301,000 | -18.4% | 4,828 | -4.9% | 0.00% | 0.0% |
Q4 2016 | $369,000 | – | 5,077 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Penn Mutual Asset Management | 36,283 | $3,120,338 | 2.93% |
Clean Yield Group | 31,263 | $2,684,554 | 1.19% |
BARD ASSOCIATES INC | 18,181 | $1,563,566 | 0.65% |
RICE HALL JAMES & ASSOCIATES, LLC | 111,634 | $9,600,524 | 0.61% |
Ranger Investment Management | 74,411 | $6,399,346 | 0.42% |
ISTHMUS PARTNERS, LLC | 21,307 | $1,832,402 | 0.26% |
Cardinal Capital Management | 11,581 | $999,344 | 0.20% |
Riverwater Partners LLC | 2,354 | $202,444 | 0.18% |
GLOBEFLEX CAPITAL L P | 9,338 | $803,068 | 0.09% |
JAMES INVESTMENT RESEARCH INC | 4,292 | $369,112 | 0.05% |